Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cogtest is a specialized clinical research organization (CRO) and technology company that provides computerized cognitive assessment tools for central nervous system (CNS) clinical trials. Founded by leading neuropsychologists, the company developed a proprietary platform of validated tests to measure cognitive performance in patients with disorders such as schizophrenia, Alzheimer's disease, and major depression. Their services include the design of cognitive endpoints, global site training, and centralized data monitoring to ensure high-quality results in complex multi-center trials. In November 2013, Cogtest was acquired by Bracket (now Signant Health), a move that combined Cogtest's scientific expertise in neuropsychology with Bracket's electronic clinical outcome assessment (eCOA) and data analytics capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cogtest.